These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16824282)

  • 1. Most commercial insulin assays fail to detect recombinant insulin analogues.
    Heald AH; Bhattacharya B; Cooper H; Ullah A; McCulloch A; Smellie S; Wark G
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):306-8. PubMed ID: 16824282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of diabetic control with Actrapid and Monotard insulins.
    Harrower AD; Archibald L
    Practitioner; 1980 Jun; 224(1344):657-8. PubMed ID: 6999491
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-reactivity of Actrapid and three insulin analogues in the Abbott IMx insulin immunoassay.
    Song D; Davidson J
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):197-8. PubMed ID: 17362590
    [No Abstract]   [Full Text] [Related]  

  • 4. Commercial insulin immunoassays fail to detect commonly prescribed insulin analogues.
    Parfitt C; Church D; Armston A; Couchman L; Evans C; Wark G; McDonald TJ
    Clin Biochem; 2015 Dec; 48(18):1354-7. PubMed ID: 26171976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of 12 recombinant insulin preparations in the Beckman Unicel DxI 800 insulin assay.
    Glenn C; Armston A
    Ann Clin Biochem; 2010 May; 47(Pt 3):264-6. PubMed ID: 20392753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: Bi-insulin IRMA preliminary assessment.
    Agin A; Jeandidier N; Gasser F; Grucker D; Sapin R
    Clin Chem Lab Med; 2006; 44(11):1379-82. PubMed ID: 17087654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative approach to the treatment of diabetes mellitus.
    Valuev LI; Starosel'tseva LK; Valuev IL; Vanchugova LV; Khadzhiev SN
    Dokl Biol Sci; 2017 Jan; 472(1):15-16. PubMed ID: 28429265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [INSULIN RAPITARD AND INSULIN ACTRAPID].
    SCHLICHTKRULL J; MUNCK O; JERSILD M
    Ugeskr Laeger; 1964 Jun; 126():820-6. PubMed ID: 14161921
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin analogues in the management of diabetes.
    Vázquez-Carrera M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of biosynthetic human insulin and purified pork insulin. Studies in insulin-resistant obese patients using the insulin suppression test].
    Richard JL; Rodier M; Cavalie G; Lachkar H; Orsetti A; Monnier L; Mirouze J
    Diabete Metab; 1986 Feb; 12(1):6-9. PubMed ID: 2870943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of efficacy and safety of human insulin (Novo) in the treatment of insulin-dependent diabetes mellitus: a double-blind, multicenter clinical trial.
    Karam J; Brink S; Clements R; Miller L; Raskin P
    Diabetes Care; 1983; 6 Suppl 1():56-60. PubMed ID: 6343041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinkinetic and -dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analogue (B28Asp).
    Wiefels K; Hübinger A; Dannehl K; Gries FA
    Horm Metab Res; 1995 Sep; 27(9):421-4. PubMed ID: 8557242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification.
    Heurtault B; Reix N; Meyer N; Gasser F; Wendling MJ; Ratomponirina C; Jeandidier N; Sapin R; Agin A
    Clin Chem Lab Med; 2014 Mar; 52(3):355-62. PubMed ID: 24150210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized pharmacotherapy in diabetes care using clinical pharmacology data of basal insulin analogues.
    Farahani P
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):451-5. PubMed ID: 24766272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog).
    Roper NA; Bilous RW
    Diabet Med; 1998 Dec; 15(12):1063-4. PubMed ID: 9868982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple daily insulin injections: a multicentre study on acceptability and efficacy.
    Houtzagers CM; van der Velde EA
    Neth J Med; 1988 Aug; 33(1-2):16-25. PubMed ID: 3073315
    [No Abstract]   [Full Text] [Related]  

  • 18. Variability of insulin absorption and insulin action.
    Heinemann L
    Diabetes Technol Ther; 2002; 4(5):673-82. PubMed ID: 12450450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human insulin.
    Roberts RJ
    Iowa Med; 1984 Mar; 74(3):116-8. PubMed ID: 6373658
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the insulin analogue [LYS(B28),PRO(B29)] on blood glucose control.
    Trautmann ME
    Horm Metab Res; 1994 Dec; 26(12):588-90. PubMed ID: 7705764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.